Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.
Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...
Elon Musk’s substantial support for Donald Trump’s re-election has the potential to reshape regulatory oversight across his ...
It is not known how many patients the FDA ultimately approved. Musk has grand ambitions for Neuralink, saying it would facilitate speedy surgical insertions of its chip devices to treat conditions ...
As ironic as it may sound, the FDA approved a game-based digital therapeutic for the treatment of ADHD in kids. For context, in June 2020, the FDA approved the first prescription-only game-based ...
Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions on the market. But when the drug was declared to be in shortage in December that same ...
Oct. 16, 2024 — Before the FDA allows prescription medicines on the market, drugmakers must prove they’re safe and effective. What’s less widely known is that most medical devices ...
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now By Robin Foster HealthDay Reporter TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making ...
At-home test results for both COVID-19 and flu appear in approximately 15 minutes, according to the FDA. The Healgen test is for self-use by individuals 14 years or older, or for young children ...
Is there a recall on eggs? Yes, according to the FDA, there is currently a recall on eggs sold in three states: Wisconsin, Illinois and Michigan. The status of the recall is ongoing, according to ...
NEW YORK — Under new FDA regulations, all mammography facilities have to notify women of their level of breast density. Until now, this critical piece of information wasn't required to be shared ...